WHO Collaborating Center for Metabolic Bone Disorders
Designation
The Program's outstanding achievements in clinical care, research, and education in disorders of calcium and bone metabolism, led to the coveted designation by the World Health Organization as a “WHO Collaborating Center (WHO-CC) for Osteoporosis and Metabolic Bone Disorders” in 2010 and the re-designation in 2014, and again in 2020.
Terms of Reference and Activities
Director / Head
- Dr Ghada El-Hajj Fuleihan
- Dr Asma Arabi
Terms of Reference
- Support WHO in assessing the current situation and morbidity burden of hypovitaminosis D and osteoporosis in Member States of EMR
- Support WHO in providing and disseminating essential PHC packages for osteoporosis
Subjects
- Nutrition
- Noncommunicable diseases other than those specifically mentioned
Types of Activity
WHO-CC Related Outputs
- Countries enabled to develop and monitor implementation of action plans to tackle malnutrition in all its forms and achieve the global nutrition targets 2025 and the nutrition components of the Sustainable Development Goals
- Norms, standards and policy options for promoting population dietary goals and the global nutrition targets 2025 and nutrition-related Sustainable Development Goals developed, adopted and integrated into current national health and development plans
- Development and implementation of national multisectoral policies and plans to prevent and control noncommunicable diseases accelerated– For more details press Here - (FRAX based guidelines / Vitamin D systematic Reviews)